← 產業報告目錄
Radiopharmaceuticals in PET Imaging Market Size, Share & Trends Analysis Report By Radioisotope Type (F-18 FDG, F-18 Fiorbetapir, F-18 Fiobetaben, F-18 Sodium Fluoride), By Application (Oncology (Lung Cancer, Breast Cancer), Cardiology, Neurology (Dementia, Parkinson's Disease), Others), By End-User (Hospitals and Clinics, Medical Imaging Centers), By Region, And By Segment Forecasts, 2025-2034.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-08頁數 180報告編號 INSIGHTACE-ea1a5de1ec
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 1.56 Bn as of 2024, the global Radiopharmaceuticals in PET Imaging Market is expected to climb to USD 3.02 Bn by 2034, reflecting a compound annual growth rate of 7.1% over the 2025–2034 period.
Radiopharmaceuticals in PET Imaging encompasses and treatment of a number of illnesses, most notably cancer, neurological disorders, and cardiov. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiopharmaceuticals in PET Imaging Market Snapshot
Chapter 4. Global Radiopharmaceuticals in PET Imaging Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Radiopharmaceuticals in PET Imaging Market Industry Trends
4.10. Global Radiopharmaceuticals in PET Imaging Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Radiopharmaceuticals in PET Imaging Market Segmentation 1: By Radioisotope Type, Estimates & Trend Analysis
5.1. Market Share by Radioisotope Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Radioisotope Type:
5.2.1. F-18
5.2.1.1. F-18 FDG
5.2.1.2. F-18 Fiorbetapir
5.2.1.3. F-18 Fiobetaben
5.2.1.4. F-18 Sodium Fluoride
5.2.1.5. Others
5.2.2. Rb-82
5.2.3. G-68
5.2.4. Other PET Isotopes
Chapter 6. Radiopharmaceuticals in PET Imaging Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Oncology
6.2.1.1. Lung Cancer
6.2.1.2. Breast Cancer
6.2.1.3. Others
6.2.2. Cardiology
6.2.3. Neurology
6.2.3.1. Dementia
6.2.3.2. Parkinson's Disease
6.2.3.3. Others
6.2.4. Others
Chapter 7. Radiopharmaceuticals in PET Imaging Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Hospitals and Clinics
7.2.2. Medical Imaging Centers
7.2.3. Other End Users
Chapter 8. Radiopharmaceuticals in PET Imaging Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Radiopharmaceuticals in PET Imaging Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.2.3. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.3.3. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Southeast Asia
8.4.1.7. Rest of Asia Pacific
8.4.2. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.4.3. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.5.3. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East and Africa
8.6.2. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Type, 2021-2034
8.6.3. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Radiopharmaceuticals in PET Imaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Curium
9.2.2. Telix Pharmaceuticals
9.2.3. Lantheus Holdings, Inc.
9.2.4. GE Healthcare
9.2.5. Life Molecular Imaging
9.2.6. Siemens Healthineers
9.2.7. Avid Radiopharmaceuticals
9.2.8. Cardinal Health
9.2.9. Eckert & Ziegler
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們